Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Gilead Sciences EBITDA 2010-2024 | GILD

Gilead Sciences annual and quarterly EBITDA history from 2010 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • Gilead Sciences EBITDA for the quarter ending December 31, 2024 was $1.578B, a 52.28% decline year-over-year.
  • Gilead Sciences EBITDA for the twelve months ending December 31, 2024 was $3.585B, a 66.78% decline year-over-year.
  • Gilead Sciences 2023 annual EBITDA was $10.298B, a 9.17% increase from 2022.
  • Gilead Sciences 2022 annual EBITDA was $9.433B, a 21.18% decline from 2021.
  • Gilead Sciences 2021 annual EBITDA was $11.968B, a 115.6% increase from 2020.
  
Gilead Sciences Annual EBITDA
(Millions of US $)
2023 $10,298
2022 $9,433
2021 $11,968
2020 $5,551
2019 $5,691
2018 $9,629
2017 $15,410
2016 $18,791
2015 $23,291
2014 $16,315
2013 $4,869
2012 $4,288
2011 $4,092
2010 $4,228
2009 $3,742
Gilead Sciences Quarterly EBITDA
(Millions of US $)
2024-09-30 $1,578
2024-06-30 $3,338
2024-03-31 $-3,632
2023-12-31 $2,301
2023-09-30 $3,307
2023-06-30 $2,346
2023-03-31 $2,344
2022-12-31 $2,795
2022-09-30 $3,362
2022-06-30 $2,554
2022-03-31 $722
2021-12-31 $1,475
2021-09-30 $4,365
2021-06-30 $2,765
2021-03-31 $3,363
2020-12-31 $3,078
2020-09-30 $2,356
2020-06-30 $-2,634
2020-03-31 $2,751
2019-12-31 $1,443
2019-09-30 $-1,126
2019-06-30 $2,778
2019-03-31 $2,596
2018-12-31 $1,502
2018-09-30 $2,981
2018-06-30 $2,636
2018-03-31 $2,510
2017-12-31 $2,688
2017-09-30 $4,109
2017-06-30 $4,552
2017-03-31 $4,061
2016-12-31 $4,337
2016-09-30 $4,698
2016-06-30 $4,822
2016-03-31 $4,934
2015-12-31 $5,899
2015-09-30 $5,863
2015-06-30 $5,889
2015-03-31 $5,640
2014-12-31 $4,605
2014-09-30 $3,748
2014-06-30 $4,678
2014-03-31 $3,284
2013-12-31 $1,325
2013-09-30 $1,217
2013-06-30 $1,227
2013-03-31 $1,100
2012-12-31 $1,180
2012-09-30 $1,115
2012-06-30 $1,127
2012-03-31 $866
2011-12-31 $941
2011-09-30 $1,077
2011-06-30 $1,092
2011-03-31 $983
2010-12-31 $907
2010-09-30 $1,048
2010-06-30 $1,051
2010-03-31 $1,221
2009-12-31 $1,130
2009-09-30 $951
2009-06-30 $814
2009-03-31 $847
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $138.373B $28.754B
Gilead Sciences is a pioneer in developing drugs for the treatment of human immunodeficiency virus, liver diseases, hematology/oncology diseases and inflammation/respiratory diseases. The company has a strong HIV franchise with key HIV/AIDS therapies like tenofovir alafenamide based products - Genvoya, Odefsey, Descovy, Biktarvy and Truvada. The portfolio also includes hepatitis C virus drugs like Harvoni and Epclusa and HBV drug. The first cell therapy approved for the treatment of adult patients with relapsed or refractory large B-cell lymphoma, has diversified Gilead's portfolio. Tecartus, another CAR T-cell therapy, was granted an accelerated approval in the United States for the treatment of relapsed or refractory mantle cell lymphoma. The company is also working on diversifying and growing its business beyond antivirals into other therapeutic areas. Gilead is also making inroads in the oncology space with strategic collaborations and acquisitions.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $231.626B 18.17
Amgen (AMGN) United States $166.383B 15.63
Vertex Pharmaceuticals (VRTX) United States $123.683B 0.00
Bristol Myers Squibb (BMY) United States $117.457B 50.77
CSL (CSLLY) Australia $79.187B 0.00
Regeneron Pharmaceuticals (REGN) United States $77.976B 17.97
GSK (GSK) United Kingdom $76.851B 9.18
Argenex SE (ARGX) Netherlands $38.044B 0.00
Alnylam Pharmaceuticals (ALNY) United States $32.227B 0.00
BioNTech SE (BNTX) Germany $28.045B 0.00
BeiGene (ONC) Cayman Islands $25.296B 0.00
Biogen (BIIB) United States $20.678B 8.58
Genmab (GMAB) Denmark $14.890B 18.15
Illumina (ILMN) United States $14.883B 38.35
Genmab (GNMSF) Denmark $14.742B 15.19
Insmed (INSM) United States $14.485B 0.00
Incyte (INCY) United States $14.323B 435.35
Intra-Cellular Therapies (ITCI) United States $13.671B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.151B 25.37
Moderna (MRNA) United States $13.079B 0.00
Swedish Orphan Biovitrum (BIOVF) Sweden $10.851B 27.71
Exelixis (EXEL) United States $10.392B 21.22
Bio-Techne Corp (TECH) United States $10.364B 39.73
Vaxcyte (PCVX) United States $10.180B 0.00
Sarepta Therapeutics (SRPT) United States $10.083B 91.00
Exact Sciences (EXAS) United States $9.526B 0.00
Repligen (RGEN) United States $9.230B 111.31
Ascendis Pharma (ASND) Denmark $9.168B 0.00
QIAGEN (QGEN) Netherlands $8.854B 17.85
Bio-Rad Laboratories (BIO.B) United States $8.741B 30.27
Jazz Pharmaceuticals (JAZZ) Ireland $8.264B 8.08
Roivant Sciences (ROIV) United Kingdom $7.507B 0.00
Halozyme Therapeutics (HALO) United States $7.204B 14.92
Zealand Pharma (ZLDPF) Denmark $7.102B 0.00
Telix Pharmaceuticals (TLX) Australia $7.051B 0.00
Revolution Medicines (RVMD) United States $6.936B 0.00
Legend Biotech (LEGN) United States $6.754B 0.00
Axsome Therapeutics (AXSM) United States $6.375B 0.00
Blueprint Medicines (BPMC) United States $5.910B 0.00
Alkermes (ALKS) Ireland $5.776B 14.68
Cytokinetics (CYTK) United States $5.681B 0.00
Nuvalent (NUVL) United States $5.544B 0.00
Krystal Biotech (KRYS) United States $5.384B 56.29
Verona Pharma American Depositary Share (VRNA) United Kingdom $5.368B 0.00
Guardant Health (GH) United States $5.238B 0.00
TG Therapeutics (TGTX) United States $4.517B 0.00
SpringWorks Therapeutics (SWTX) United States $4.238B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.995B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.870B 0.00
PTC Therapeutics (PTCT) United States $3.858B 0.00
ADMA Biologics Inc (ADMA) United States $3.669B 38.80
Avidity Biosciences (RNA) United States $3.643B 0.00
Zai Lab (ZLAB) China $3.606B 0.00
Biohaven (BHVN) United States $3.593B 0.00
Alvotech (ALVO) Luxembourg $3.579B 0.00
Scholar Rock Holding (SRRK) United States $3.479B 0.00
Immunovant (IMVT) United States $3.470B 0.00
Akero Therapeutics (AKRO) United States $3.462B 0.00
Apellis Pharmaceuticals (APLS) United States $3.410B 0.00
Arcellx (ACLX) United States $3.407B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.359B 0.00
Viking Therapeutics (VKTX) United States $3.254B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.241B 24.97
Merus (MRUS) Netherlands $3.201B 0.00
Metsera (MTSR) United States $3.071B 0.00
Denali Therapeutics (DNLI) United States $2.975B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.925B 0.00
Amicus Therapeutics (FOLD) United States $2.870B 155.67
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.685B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.618B 0.00
Vericel (VCEL) United States $2.583B 872.17
Beam Therapeutics (BEAM) United States $2.550B 0.00
Twist Bioscience (TWST) United States $2.458B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.446B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.378B 0.00
Edgewise Therapeutics (EWTX) United States $2.368B 0.00
NovoCure (NVCR) Jersey $2.298B 0.00
Kymera Therapeutics (KYMR) United States $2.287B 0.00
ImmunityBio (IBRX) United States $2.244B 0.00
Ligand Pharmaceuticals (LGND) United States $2.212B 55.22
Protagonist Therapeutics (PTGX) United States $2.210B 8.57
Mesoblast (MESO) Australia $2.062B 0.00
CG Oncology (CGON) United States $2.036B 0.00
Agios Pharmaceuticals (AGIO) United States $2.032B 0.00
Certara (CERT) United States $2.020B 57.04
Harmony Biosciences Holdings (HRMY) United States $1.949B 16.20
Bavarian Nordic (BVNRY) Denmark $1.892B 11.59
Travere Therapeutics (TVTX) United States $1.884B 0.00
IDEAYA Biosciences (IDYA) United States $1.865B 0.00
Belite Bio (BLTE) United States $1.799B 0.00
Janux Therapeutics (JANX) United States $1.762B 0.00
Galapagos (GLPG) Belgium $1.750B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.741B 0.00
Vera Therapeutics (VERA) United States $1.722B 0.00
Ascentage Pharma Group - (AAPG) China $1.707B 0.00
Iovance Biotherapeutics (IOVA) United States $1.692B 0.00
Dynavax Technologies (DVAX) United States $1.665B 74.56
Disc Medicine (IRON) United States $1.626B 0.00
WAVE Life Sciences (WVE) Singapore $1.598B 0.00
MannKind (MNKD) United States $1.572B 40.71
GRAIL (GRAL) United States $1.522B 0.00
Apogee Therapeutics (APGE) United States $1.503B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.500B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.450B 0.00
Geron (GERN) United States $1.445B 0.00
NeoGenomics (NEO) United States $1.435B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.417B 0.00
Celldex Therapeutics (CLDX) United States $1.415B 0.00
Fortrea Holdings (FTRE) United States $1.363B 43.40
Liquidia Technologies (LQDA) United States $1.345B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.338B 0.00
Vir Biotechnology (VIR) United States $1.304B 0.00
Nurix Therapeutics (NRIX) United States $1.279B 0.00
Viridian Therapeutics (VRDN) United States $1.262B 0.00
Myriad Genetics (MYGN) United States $1.254B 0.00
Praxis Precision Medicines (PRAX) United States $1.243B 0.00
Adaptive Biotechnologies (ADPT) United States $1.243B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.228B 0.00
Structure Therapeutics (GPCR) United States $1.204B 0.00
Novavax (NVAX) United States $1.187B 0.00
Intellia Therapeutics (NTLA) United States $1.172B 0.00
ANI Pharmaceuticals (ANIP) United States $1.169B 15.92
MiMedx (MDXG) United States $1.168B 30.58
Pacira BioSciences (PCRX) United States $1.166B 10.98
Arvinas (ARVN) United States $1.152B 0.00
Spyre Therapeutics (SYRE) United States $1.093B 0.00
89BIO (ETNB) United States $1.075B 0.00
Arcus Biosciences (RCUS) United States $1.068B 0.00
Replimune (REPL) United States $1.048B 0.00
Gyre Therapeutics (GYRE) United States $0.987B 0.00
Zymeworks (ZYME) United States $0.961B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.916B 0.00
AbCellera Biologics (ABCL) Canada $0.883B 0.00
ArriVent BioPharma (AVBP) United States $0.851B 0.00
Oculis Holding AG (OCS) Switzerland $0.846B 0.00
Sionna Therapeutics (SION) $0.838B 0.00
Pharvaris (PHVS) Netherlands $0.826B 0.00
Cogent Biosciences (COGT) United States $0.824B 0.00
Prothena (PRTA) Ireland $0.820B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.777B 0.00
Opthea (OPT) Australia $0.754B 0.00
Immunome (IMNM) United States $0.746B 0.00
CureVac (CVAC) Germany $0.732B 5.95
Castle Biosciences (CSTL) United States $0.710B 126.80
Bicara Therapeutics (BCAX) United States $0.706B 0.00
Anavex Life Sciences (AVXL) United States $0.703B 0.00
Nuvation Bio (NUVB) United States $0.700B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.696B 0.00
Cytek Biosciences (CTKB) United States $0.672B 0.00
Tyra Biosciences (TYRA) United States $0.649B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Sana Biotechnology (SANA) United States $0.643B 0.00
Dianthus Therapeutics (DNTH) United States $0.639B 0.00
GH Research (GHRS) Ireland $0.635B 0.00
Arbutus Biopharma (ABUS) United States $0.633B 0.00
Pharming Group (PHAR) Netherlands $0.629B 0.00
LENZ Therapeutics (LENZ) United States $0.620B 0.00
CorMedix Inc (CRMD) United States $0.613B 0.00
Kura Oncology (KURA) United States $0.613B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.601B 0.00
Pharming Group (PHGUF) Netherlands $0.587B 0.00
MeiraGTx Holdings (MGTX) United States $0.560B 0.00
UniQure (QURE) Netherlands $0.560B 0.00
Immatics (IMTX) Germany $0.555B 0.00
Oric Pharmaceuticals (ORIC) United States $0.537B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.527B 0.00
AnaptysBio (ANAB) United States $0.523B 0.00
Absci (ABSI) United States $0.514B 0.00
Precigen (PGEN) United States $0.513B 0.00
Cullinan Therapeutics (CGEM) United States $0.508B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.500B 0.00
Rapport Therapeutics (RAPP) United States $0.484B 0.00
Cartesian Therapeutics (RNAC) United States $0.483B 0.00
Entrada Therapeutics (TRDA) United States $0.481B 8.08
Abivax SA (ABVX) France $0.475B 0.00
Maze Therapeutics (MAZE) United States $0.474B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.466B 0.00
Mineralys Therapeutics (MLYS) United States $0.461B 0.00
Sage Therapeutics (SAGE) United States $0.460B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.452B 0.00
Stoke Therapeutics (STOK) United States $0.450B 0.00
Allogene Therapeutics (ALLO) United States $0.449B 0.00
PureTech Health (PRTC) United States $0.442B 0.00
Upstream Bio (UPB) United States $0.441B 0.00
Keros Therapeutics (KROS) United States $0.437B 0.00
Chimerix (CMRX) United States $0.428B 0.00
Compass Therapeutics (CMPX) United States $0.428B 0.00
ChromaDex (CDXC) United States $0.420B 550.00
Mereo BioPharma Group - (MREO) United Kingdom $0.417B 0.00
Kamada (KMDA) Israel $0.416B 25.82
Celcuity (CELC) United States $0.415B 0.00
Humacyte (HUMA) United States $0.405B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.403B 0.00
Tectonic Therapeutic (TECX) United States $0.402B 0.00
MaxCyte (MXCT) United States $0.399B 0.00
Erasca (ERAS) United States $0.399B 0.00
Emergent Biosolutions (EBS) United States $0.388B 0.00
Prime Medicine (PRME) United States $0.380B 0.00
Alpha Teknova (TKNO) United States $0.376B 0.00
Eton Pharmaceuticals (ETON) United States $0.371B 0.00
Astria Therapeutics (ATXS) United States $0.369B 0.00
Aura Biosciences (AURA) United States $0.368B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.365B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.359B 0.00
Candel Therapeutics (CADL) United States $0.356B 0.00
MBX Biosciences (MBX) United States $0.346B 0.00
REGENXBIO (RGNX) United States $0.343B 0.00
Northwest Biotherapeutics (NWBO) United States $0.341B 0.00
Codexis (CDXS) United States $0.334B 0.00
Trevi Therapeutics (TRVI) United States $0.331B 0.00
ATyr Pharma (ATYR) United States $0.322B 0.00
Terns Pharmaceuticals (TERN) United States $0.317B 0.00
Gossamer Bio (GOSS) United States $0.295B 0.00
Zenas BioPharma (ZBIO) United States $0.293B 0.00
Foghorn Therapeutics (FHTX) United States $0.287B 0.00
Annexon (ANNX) United States $0.282B 0.00
XOMA Royalty (XOMA) United States $0.277B 0.00
Neumora Therapeutics (NMRA) United States $0.276B 0.00
Olema Pharmaceuticals (OLMA) United States $0.276B 0.00
Prima BioMed (IMMP) Australia $0.275B 0.00
Design Therapeutics (DSGN) United States $0.272B 0.00
EnGene Holdings (ENGN) Canada $0.270B 0.00
ITeos Therapeutics (ITOS) United States $0.268B 0.00
DiaMedica Therapeutics (DMAC) United States $0.267B 0.00
Atea Pharmaceuticals (AVIR) United States $0.265B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.263B 0.00
Rezolute (RZLT) United States $0.262B 0.00
ACELYRIN, INC (SLRN) United States $0.259B 0.00
AC Immune (ACIU) Switzerland $0.257B 0.00
Anika Therapeutics (ANIK) United States $0.255B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.255B 0.00
Septerna (SEPN) United States $0.254B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.254B 0.00
Bright Minds Biosciences (DRUG) United States $0.253B 0.00
Tango Therapeutics (TNGX) United States $0.252B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.249B 0.00
Verastem (VSTM) United States $0.247B 0.00
Alumis (ALMS) United States $0.247B 0.00
Benitec Biopharma (BNTC) United States $0.247B 0.00
Neurogene (NGNE) United States $0.247B 0.00
Abeona Therapeutics (ABEO) United States $0.239B 0.00
Amarin (AMRN) Ireland $0.236B 0.00
Cardiff Oncology (CRDF) United States $0.233B 0.00
Semper Paratus Acquisition (TVGN) United States $0.231B 0.00
Urogen Pharma (URGN) United States $0.228B 0.00
Solid Biosciences (SLDB) United States $0.226B 0.00
Palvella Therapeutics (PVLA) United States $0.224B 0.00
Voyager Therapeutics (VYGR) United States $0.224B 5.77
Kodiak Sciences (KOD) United States $0.223B 0.00
BioStem Technologies (BSEM) $0.220B 19.42
Monopar Therapeutics (MNPR) United States $0.220B 0.00
Innate Pharma S.A (IPHA) France $0.212B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.209B 0.00
Sangamo Therapeutics (SGMO) United States $0.209B 0.00
Lifecore Biomedical (LFCR) United States $0.207B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.205B 0.00
C4 Therapeutics (CCCC) United States $0.204B 0.00
Fulcrum Therapeutics (FULC) United States $0.200B 0.00
Molecular Partners AG (MOLN) Switzerland $0.198B 0.00
Contineum Therapeutics (CTNM) United States $0.197B 0.00
GENFIT S.A (GNFT) France $0.195B 0.00
Nautilus Biotechnology (NAUT) United States $0.188B 0.00
Adocia (ADOCY) France $0.187B 0.00
Adherex Technologies (FENC) United States $0.186B 0.00
Compugen (CGEN) Israel $0.185B 103.50
Pliant Therapeutics (PLRX) United States $0.184B 0.00
Ocugen (OCGN) United States $0.184B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.182B 0.00
Inhibrx Biosciences (INBX) United States $0.181B 0.00
CARGO Therapeutics (CRGX) United States $0.180B 0.00
INmune Bio (INMB) United States $0.177B 0.00
Alector (ALEC) United States $0.174B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.173B 0.00
ScPharmaceuticals (SCPH) United States $0.167B 0.00
Editas Medicine (EDIT) United States $0.166B 0.00
Genelux (GNLX) United States $0.162B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.159B 0.00
Third Harmonic Bio (THRD) United States $0.156B 0.00
BioAge Labs (BIOA) United States $0.156B 0.00
Greenwich LifeSciences (GLSI) United States $0.156B 0.00
Fate Therapeutics (FATE) United States $0.155B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.155B 0.00
Inventiva S.A (IVA) France $0.153B 0.00
Invivyd (IVVD) United States $0.148B 0.00
Cidara Therapeutics (CDTX) United States $0.144B 0.00
Checkpoint Therapeutics (CKPT) United States $0.144B 0.00
Actuate Therapeutics (ACTU) United States $0.143B 0.00
Nuvectis Pharma (NVCT) United States $0.142B 0.00
Puma Biotechnology (PBYI) United States $0.142B 6.02
Adaptimmune Therapeutics (ADAP) United Kingdom $0.141B 0.00
Sutro Biopharma (STRO) United States $0.141B 0.00
Nkarta (NKTX) United States $0.139B 0.00
2seventy Bio (TSVT) United States $0.136B 0.00
Seres Therapeutics (MCRB) United States $0.135B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.134B 0.00
Coherus BioSciences (CHRS) United States $0.133B 0.00
Renovaro (RENB) United States $0.133B 0.00
Instil Bio (TIL) United States $0.132B 0.00
Seer (SEER) United States $0.131B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.130B 0.00
Kyverna Therapeutics (KYTX) United States $0.125B 0.00
Black Diamond Therapeutics (BDTX) United States $0.123B 0.00
TuHURA Biosciences (HURA) United States $0.123B 0.00
Biomea Fusion (BMEA) United States $0.121B 0.00
Caribou Biosciences (CRBU) United States $0.116B 0.00
TScan Therapeutics (TCRX) United States $0.114B 0.00
Sagimet Biosciences (SGMT) United States $0.113B 0.00
Elutia (ELUT) United States $0.111B 0.00
Ventyx Biosciences (VTYX) United States $0.110B 0.00
Vigil Neuroscience (VIGL) United States $0.109B 0.00
EXoZymes (EXOZ) United States $0.108B 0.00
Immunic (IMUX) United States $0.108B 0.00
InflaRx (IFRX) Germany $0.107B 0.00
TELA Bio (TELA) United States $0.104B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.101B 0.00
Coya Therapeutics (COYA) United States $0.099B 0.00
CAMP4 Therapeutics (CAMP) United States $0.098B 0.00
Cabaletta Bio (CABA) United States $0.096B 0.00
Climb Bio (CLYM) United States $0.095B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.095B 0.00
Alpha Cognition (ACOG) Canada $0.095B 0.00
XBiotech (XBIT) United States $0.093B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.093B 0.00
Artiva Biotherapeutics (ARTV) United States $0.092B 0.00
HilleVax (HLVX) United States $0.091B 0.00
Vor Biopharma (VOR) $0.091B 0.00
BioHarvest Sciences (BHST) Canada $0.090B 0.00
Akoya Biosciences (AKYA) United States $0.090B 0.00
Citius Oncology (CTOR) United States $0.089B 0.00
Elicio Therapeutics (ELTX) United States $0.089B 0.00
Skye Bioscience (SKYE) United States $0.088B 0.00
Adagene (ADAG) China $0.088B 0.00
Rani Therapeutics Holdings (RANI) United States $0.087B 0.00
Zura Bio (ZURA) United States $0.087B 0.00
MediciNova (MNOV) United States $0.086B 0.00
Jasper Therapeutics (JSPR) United States $0.086B 0.00
Tenaya Therapeutics (TNYA) United States $0.086B 0.00
Theratechnologies (THTX) Canada $0.085B 0.00
DBV Technologies S.A (DBVT) France $0.085B 0.00
Alto Neuroscience (ANRO) United States $0.084B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.084B 0.00
Cellectis S.A (CLLS) France $0.083B 0.00
Shattuck Labs (STTK) United States $0.082B 0.00
Adlai Nortye (ANL) Cayman Islands $0.082B 0.00
Galena Biopharma (SLS) United States $0.082B 0.00
Cue Biopharma (CUE) United States $0.080B 0.00
IGM Biosciences (IGMS) United States $0.080B 0.00
Adverum Biotechnologies (ADVM) United States $0.080B 0.00
Inozyme Pharma (INZY) United States $0.080B 0.00
VistaGen Therapeutics (VTGN) United States $0.079B 0.00
X4 Pharmaceuticals (XFOR) United States $0.077B 0.00
Scilex Holding (SCLX) United States $0.077B 0.00
I-Mab (IMAB) China $0.077B 0.00
Adicet Bio (ACET) United States $0.076B 0.00
ZIVO Bioscience (ZIVO) United States $0.076B 0.00
PepGen (PEPG) United States $0.075B 0.00
Agenus (AGEN) United States $0.074B 0.00
Entera Bio (ENTX) Israel $0.074B 0.00
Genenta Science S.p.A (GNTA) Italy $0.071B 0.00
Aerovate Therapeutics (AVTE) United States $0.070B 0.00
BeyondSpring (BYSI) United States $0.070B 0.00
IO Biotech (IOBT) Denmark $0.069B 0.00
Mersana Therapeutics (MRSN) United States $0.069B 0.00
Aadi Bioscience (AADI) United States $0.067B 0.00
Ikena Oncology (IKNA) United States $0.067B 0.00
Clearside Biomedical (CLSD) United States $0.067B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.065B 0.00
Aligos Therapeutics (ALGS) United States $0.064B 0.00
VTv Therapeutics (VTVT) United States $0.063B 0.00
Applied Therapeutics (APLT) United States $0.063B 0.00
23andMe Holding (ME) United States $0.062B 0.00
Forte Biosciences (FBRX) United States $0.062B 0.00
Quince Therapeutics (QNCX) United States $0.062B 0.00
Oncolytics Biotech (ONCY) Canada $0.061B 0.00
BGM Group (BGM) China $0.060B 0.00
Werewolf Therapeutics (HOWL) United States $0.060B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.060B 0.00
Kronos Bio (KRON) United States $0.059B 0.00
CytomX Therapeutics (CTMX) United States $0.058B 4.38
Achilles Therapeutics (ACHL) United Kingdom $0.057B 0.00
ALX Oncology Holdings (ALXO) United States $0.056B 0.00
Repare Therapeutics (RPTX) Canada $0.054B 0.00
Inovio Pharmaceuticals (INO) United States $0.053B 0.00
Immuneering (IMRX) United States $0.052B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.051B 0.00
Rein Therapeutics (RNTX) United States $0.051B 0.00
Oncobiologics (OTLK) United States $0.049B 0.00
Estrella Immunopharma (ESLA) United States $0.048B 0.00
PDS Biotechnology (PDSB) United States $0.048B 0.00
Immix Biopharma (IMMX) United States $0.047B 0.00
Connect Biopharma Holdings (CNTB) United States $0.047B 0.00
Kezar Life Sciences (KZR) United States $0.045B 0.00
Lantern Pharma (LTRN) United States $0.045B 0.00
Spero Therapeutics (SPRO) United States $0.044B 11.50
Fortress Biotech (FBIO) United States $0.043B 0.00
Precision BioSciences (DTIL) United States $0.043B 0.00
Boundless Bio (BOLD) United States $0.043B 0.00
MiNK Therapeutics (INKT) United States $0.042B 0.00
Atara Biotherapeutics (ATRA) United States $0.042B 0.00
Medicus Pharma (MDCX) Canada $0.041B 0.00
Xilio Therapeutics (XLO) United States $0.041B 0.00
Rapt Therapeutics (RAPT) United States $0.041B 0.00
Grace Therapeutics (GRCE) Canada $0.041B 0.00
Dyadic (DYAI) United States $0.041B 0.00
Ovid Therapeutics (OVID) United States $0.041B 0.00
KALA BIO (KALA) United States $0.040B 0.00
Generation Bio (GBIO) United States $0.040B 0.00
Abpro Holdings (ABP) United States $0.039B 0.00
Bluebird Bio (BLUE) United States $0.039B 0.00
FibroBiologics (FBLG) United States $0.039B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.039B 0.00
Celularity (CELU) United States $0.038B 0.00
Alterity Therapeutics - (ATHE) Australia $0.038B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.037B 0.00
Femasys (FEMY) United States $0.037B 0.00
OKYO Pharma (OKYO) $0.037B 0.00
Cadrenal Therapeutics (CVKD) United States $0.036B 0.00
Clene (CLNN) United States $0.035B 0.00
Elevation Oncology (ELEV) United States $0.035B 0.00
Opus Genetics (IRD) United States $0.034B 0.00
AN2 Therapeutics (ANTX) United States $0.034B 0.00
Intensity Therapeutics (INTS) United States $0.033B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.032B 0.00
Passage Bio (PASG) United States $0.032B 0.00
Pluri (PLUR) Israel $0.031B 0.00
Rallybio (RLYB) United States $0.031B 0.00
Q32 Bio (QTTB) United States $0.031B 0.00
UNITY Biotechnology (UBX) United States $0.031B 0.00
CalciMedica (CALC) United States $0.030B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.030B 0.00
Pulmatrix (PULM) United States $0.029B 0.00
Equillium (EQ) United States $0.028B 0.00
Annovis Bio (ANVS) United States $0.028B 0.00
Dare Bioscience (DARE) United States $0.027B 0.00
Lexaria Bioscience (LEXX) Canada $0.027B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.027B 0.00
Cyclo Therapeutics (CYTH) United States $0.026B 0.00
Enzo Biochem (ENZ) United States $0.026B 0.00
Promis Neurosciences (PMN) Canada $0.026B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.026B 0.00
Onconetix (ONCO) United States $0.026B 0.00
Allakos (ALLK) United States $0.026B 0.00
Curis (CRIS) United States $0.026B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.025B 0.00
Chemomab Therapeutics (CMMB) Israel $0.024B 0.00
NKGen Biotech (NKGN) United States $0.024B 0.00
RenovoRx (RNXT) United States $0.024B 0.00
Cognition Therapeutics (CGTX) United States $0.023B 0.00
Cara Therapeutics (CARA) United States $0.023B 0.00
Longeveron (LGVN) United States $0.022B 0.00
Beyond Air (XAIR) United States $0.022B 0.00
Tenax Therapeutics (TENX) United States $0.021B 0.00
Exicure (XCUR) United States $0.021B 0.00
HOOKIPA Pharma (HOOK) United States $0.021B 0.00
NextCure (NXTC) United States $0.021B 0.00
Lisata Therapeutics (LSTA) United States $0.021B 0.00
LakeShore Biopharma (LSB) China $0.021B 0.00
IN8bio (INAB) United States $0.020B 0.00
Bolt Biotherapeutics (BOLT) United States $0.019B 0.00
Cocrystal Pharma (COCP) United States $0.019B 0.00
Senti Biosciences (SNTI) United States $0.019B 0.00
Leap Therapeutics (LPTX) United States $0.018B 0.00
BioAtla (BCAB) United States $0.018B 0.00
Spruce Biosciences (SPRB) United States $0.017B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.017B 0.00
OnKure Therapeutics (OKUR) United States $0.017B 0.00
BRIACELL THERAP (BCTX) Canada $0.017B 0.00
HCW Biologics (HCWB) United States $0.017B 0.00
Affimed (AFMD) Germany $0.016B 0.00
Synlogic (SYBX) United States $0.016B 0.00
Athira Pharma (ATHA) United States $0.016B 0.00
Gelteq (GELS) Australia $0.016B 0.00
SAB Biotherapeutics (SABS) United States $0.016B 0.00
Edesa Biotech (EDSA) Canada $0.016B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.015B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.014B 0.00
GeoVax Labs (GOVX) United States $0.014B 0.00
Aprea Therapeutics (APRE) United States $0.014B 0.00
CervoMed (CRVO) United States $0.014B 0.00
MetaVia (MTVA) United States $0.013B 0.00
Cingulate (CING) United States $0.013B 0.00
Imunon (IMNN) United States $0.013B 0.00
BioAffinity Technologies (BIAF) United States $0.012B 0.00
Sensei Biotherapeutics (SNSE) United States $0.012B 0.00
Mainz Biomed (MYNZ) Germany $0.011B 0.00
Biorestorative Therapies (BRTX) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Quantum Biopharma (QNTM) Canada $0.011B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
BioCardia (BCDA) United States $0.010B 0.00
Bionano Genomics (BNGO) United States $0.010B 0.00
ABVC BioPharma (ABVC) United States $0.010B 0.00
Turnstone Biologics (TSBX) United States $0.010B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.009B 0.00
Aptose Biosciences (APTO) Canada $0.009B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.009B 0.00
Biofrontera (BFRI) United States $0.009B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.009B 0.00
Psyence Biomedical (PBM) Canada $0.008B 0.00
Aytu BioPharma (AYTU) United States $0.008B 0.00
Omega Therapeutics (OMGA) United States $0.008B 0.00
Evogene (EVGN) Israel $0.008B 0.00
Apollomics (APLM) United States $0.008B 0.00
Cyclerion Therapeutics (CYCN) United States $0.007B 0.00
Hoth Therapeutics (HOTH) United States $0.007B 0.00
Dogwood Therapeutics (DWTX) United States $0.007B 0.00
Ensysce Biosciences (ENSC) United States $0.007B 0.00
Organovo Holdings (ONVO) United States $0.006B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.006B 0.00
Avalon GloboCare (ALBT) United States $0.006B 0.00
BioXcel Therapeutics (BTAI) United States $0.006B 0.00
Galecto (GLTO) Denmark $0.006B 0.00
Soligenix (SNGX) United States $0.006B 0.00
Silo Pharma (SILO) United States $0.006B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.006B 0.00
Carmell (CTCX) United States $0.005B 0.00
Adial Pharmaceuticals (ADIL) United States $0.005B 0.00
Alzamend Neuro (ALZN) United States $0.005B 0.00
Portage Biotech (PRTG) $0.005B 0.00
Aptevo Therapeutics (APVO) United States $0.005B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.005B 0.00
GT Biopharma (GTBP) United States $0.005B 0.00
Syros Pharmaceuticals (SYRS) United States $0.004B 0.00
Moleculin Biotech (MBRX) United States $0.004B 0.00
Novogen (KZIA) Australia $0.004B 0.00
Ocean Biomedical (OCEA) United States $0.004B 0.00
180 Life Sciences (ATNF) United States $0.004B 0.00
Purple Biotech (PPBT) Israel $0.004B 0.00
Polyrizon (PLRZ) Israel $0.004B 0.00
Synaptogenix (SNPX) United States $0.004B 0.00
GRI Bio (GRI) United States $0.004B 0.00
Allarity Therapeutics (ALLR) United States $0.004B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
GENPREX (GNPX) United States $0.003B 0.00
CNS Pharmaceuticals (CNSP) United States $0.003B 0.00
Tharimmune (THAR) United States $0.003B 0.00
Titan Pharmaceuticals (TTNP) United States $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.003B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.003B 0.00
Sunshine Biopharma (SBFM) United States $0.003B 0.00
Evaxion Biotech (EVAX) Denmark $0.003B 0.00
Windtree Therapeutics (WINT) United States $0.003B 0.00
NAYA Biosciences (NAYA) United States $0.003B 0.00
NuCana (NCNA) United Kingdom $0.003B 0.00
Mustang Bio (MBIO) United States $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Palisade Bio (PALI) United States $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Vincerx Pharma (VINC) United States $0.003B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Eyenovia (EYEN) United States $0.002B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Eterna Therapeutics (ERNA) United States $0.002B 0.00
Pasithea Therapeutics (KTTA) United States $0.002B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.001B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.001B 0.00
Revelation Biosciences (REVB) United States $0.001B 0.00
Enveric Biosciences (ENVB) United States $0.001B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.000B 0.00
Aardvark Therapeutics (AARD) $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
NeuBase Therapeutics (NBSE) United States $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00